33757-70-9Relevant academic research and scientific papers
Novel Sulfonaminoquinoline Hepcidin Antagonists
-
Page/Page column 136, (2012/09/05)
The present invention relates to novel hepcidin antagonists, pharmaceutical compositions comprising them and the use thereof as medicaments for the use in the treatment of iron metabolism disorders, such as, in particular, iron deficiency diseases and anemias, in particular anemias in connection with chronic inflammatory diseases.
Material for luminescence element and luminescence element using the same
-
, (2008/06/13)
A material for a luminescence element is described, which is a compound having a partial structure represented by the following formula (I): wherein Q1represents an atomic group necessary to form a 5- or 6-membered nitrogen-containing aromatic
